Hepatotoxicity and Its Impact on Mortality in COVID-19 Patients
Scientific Reports in Medicine · 2024
DOI: 10.37609/srinmed.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports in Medicine, 2024. Verfasst von Efraim Güzel und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective: "COVID-19-related liver damage" can occur frequently in course of COVID-19 disease and cause significant problems. Our study aimed to investigate prevalence of liver damage due to COVID-19, its risk variables, and the effect of liver damage on course of COVID-19 and mortality.
Method
One hundred patients over eighteen years of age who were hospitalized between 01.08.2021-01.03.2022 and had positive RT-PCR tests were included in our study. Impaired liver function tests were identified as having alanine aminotransferase(ALT) and aspartate aminotransferase(AST) levels exceeding upper laboratory limits.
Results
The mean age of patients included in study was 57.9 ± 14.9 years, with 49% of them being male. In our study, we had an 8% death rate and 37% of patients had abnormal liver function tests. The presence of severe disease(p
Zitieren
APA
Güzel, E., Toprak, O. B., & Aydin, K. (2024). Hepatotoxicity and Its Impact on Mortality in COVID-19 Patients. Scientific Reports in Medicine. https://doi.org/10.37609/srinmed.1
Vancouver
Güzel E, Toprak OB, Aydin K. Hepatotoxicity and Its Impact on Mortality in COVID-19 Patients. Scientific Reports in Medicine. 2024. doi:10.37609/srinmed.1
BibTeX
@article{Gzel2024,
author = {Güzel, Efraim and Toprak, Oya Baydar and Aydin, Kaniye},
title = {Hepatotoxicity and Its Impact on Mortality in COVID-19 Patients},
journal = {Scientific Reports in Medicine},
year = {2024},
doi = {10.37609/srinmed.1}
}
EUVIMED